Emanuel Martinez, MD
Psychiatry · St Augustine, FLNPI 1548264518
Payments from drug & device makers
Across 267 payments — averaging $15.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sunovion Pharmaceuticals Inc.$406
- Otsuka America Pharmaceutical, Inc.$245
- Takeda Pharmaceuticals U.S.A., Inc.$240
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$211
- Johnson & Johnson$166
- plus $1K from 17 others
What the payments were for
- Food & beverage$4,14399%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 139 | $1,769 |
| Sunovion Pharmaceuticals Inc. | 30 | $406 |
| Otsuka America Pharmaceutical, Inc. | 15 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $240 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 8 | $211 |
| Johnson & Johnson | 10 | $166 |
| Teva Pharmaceuticals USA, Inc. | 9 | $156 |
| Idorsia Pharmaceuticals US Inc | 6 | $121 |
| Livanova USA, Inc. | 1 | $118 |
| Lundbeck LLC | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $90 |
| Alkermes, Inc. | 3 | $78 |
| Corium, LLC | 4 | $69 |
| Vanda Pharmaceuticals Inc. | 3 | $67 |
| Avanir Pharmaceuticals, Inc. | 4 | $66 |
| Tris Pharma Inc | 3 | $60 |
| Supernus Pharmaceuticals, Inc. | 3 | $58 |
| Neurocrine Biosciences, Inc. | 3 | $56 |
| Neos Therapeutics, LP | 2 | $35 |
| Almatica Pharma LLC | 1 | $25 |
| Jazz Pharmaceuticals Inc. | 1 | $22 |
| Ironshore Pharmaceuticals Inc. | 1 | $20 |
| Shire North American Group Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS - Symmetry$118
How this compares
$4,190 in reported general payments places this provider in the 75th percentile of 2,059 psychiatry providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 30 | $335,945 |
| VraylarCariprazine Hcl | 69 | $107,673 |
| CaplytaLumateperone Tosylate | 33 | $58,001 |
| Lurasidone Hcl | 67 | $20,371 |
| Aripiprazole | 197 | $19,627 |
| TrintellixVortioxetine Hydrobromide | 15 | $15,250 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 242 | $11,240 |
| SavellaMilnacipran Hcl | 16 | $8,682 |
| Paliperidone ErPaliperidone | 13 | $8,319 |
| Clozapine | 92 | $7,720 |
| Quetiapine Fumarate | 295 | $6,322 |
| Vilazodone Hcl | 48 | $5,318 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 54 | $4,696 |
| Bromocriptine Mesylate | 12 | $4,666 |
| Buspirone Hcl | 217 | $4,126 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $156 | $335,94530 claims |
| AbbVieVraylar, Savella | $1,769 | $116,35485 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $211 | $58,00133 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $240 | $15,25015 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,059 psychiatry providers in Florida.
Other psychiatry in St Augustine
- Todd BroderSt Augustine$1.7M
- Edwin GomezWeston$24.9M
- Rishi KakarTamarac$23.9M
- Peter VentreOakland Park$18.7M
- Jose GamezHialeah$14.8M
- John JoyceJacksonville$13.6M
- Silvia Silva-DulucMiami$11.7M
- Kelley WilsonTampa$11.1M
- Emilio Mantero-AtienzaMiami Beach$10.9M
- Patricia JunqueraMiami$10.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.